LYEL – lyell immunopharma, inc. (US:NASDAQ)
Stock Stats
News
DELFI Diagnostics Appoints Charles Newton to Board of Directors [Yahoo! Finance]
Lyell Immunopharma (LYEL) was upgraded by Wall Street Zen from "sell"
Lyell Immunopharma, Inc. (LYEL) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript [Seeking Alpha]
A First Look At Lyell Immunopharma [Seeking Alpha]
Lyell Immunopharma (LYEL) is now covered by Needham & Company LLC. They set a "buy" rating and a $44.00 price target on the stock.
Form ARS Lyell Immunopharma, Inc. For: Dec 31
Form DEFA14A Lyell Immunopharma, Inc.
Form DEF 14A Lyell Immunopharma, Inc. For: Jun 10
Form SCHEDULE 13G Lyell Immunopharma, Inc. Filed by: Euler Fund, L.P.
Form EFFECT Lyell Immunopharma, Inc.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.